Avaleht › Vähk (kõik liigid) › Texas › Austin
Vähk (kõik liigid) kliinilised uuringud linnas Austin, TX
20 uuringut haiguse Vähk (kõik liigid) jaoks otsivad osalejaid linnas Austin ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
VärbamineFaas 2
- Texas Oncology-Austin North /ID# 279958, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
VärbamineFaas 3
- Texas Oncology, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
VärbamineFaas 1
- NEXT Oncology, Austin
Prospective Study to Assess a Diagnostic Aid for Cancer
VärbamineVaatlusuuring
- Premier Family Physicians, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
VärbamineFaas 2
- Dell Medical School, University of Texas at Austin, Austin
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
VärbamineFaas 1/2
- NEXT Oncology ( Site 1010), Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
VärbamineFaas 1
- NEXT Oncology - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
VärbamineFaas 3
- USO - Texas Oncology, Austin
Project: Every Child for Younger Patients With Cancer
VärbamineVaatlusuuring
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
VärbamineFaas 1
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
VärbamineFaas 1
- Texas Oncology - Central/South Texas /ID# 268563, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
VärbamineFaas 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
VärbamineFaas 2/3
- Texas Oncology - South Austin /ID# 276033, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
VärbamineFaas 2
- Texas Oncology - Austin Central, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
VärbamineFaas 1
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
VärbamineFaas 1
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
VärbamineFaas 1/2
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
VärbamineFaas 1/2
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
VärbamineFaas 1/2
- NEXT Oncology Austin, Austin
Vähk (kõik liigid) uuringud teistes linnades
- Houston, TX121 uuringut
- New York City, NY110 uuringut
- Boston, MA86 uuringut
- Los Angeles, CA73 uuringut
- Nashville, TN65 uuringut
- Philadelphia, PA59 uuringut
- Durham, NC58 uuringut
- Washington, DC58 uuringut
- Chicago, IL51 uuringut
- Seattle, WA49 uuringut
- Atlanta, GA49 uuringut
- Arlington, VA48 uuringut
Muud uuringud linnas Austin
- Mitteväikerakuline kopsuvähk30 uuringut
- Rasvumine20 uuringut
- Metastaatiline vähk19 uuringut
- Käär- ja pärasoolevähk19 uuringut
- Südamepuudulikkus18 uuringut
- Rinnavähk18 uuringut
- Ülekaalulisus18 uuringut
- Munasarjavähk17 uuringut
- Endomeetriumivähk15 uuringut
- Eesnäärmevähk15 uuringut
- Depressioon14 uuringut
- Kolmiknegatiivne rinnavähk13 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.